Jubilant Pharmova Limited (JUBLPHARMA) Share Price Today, Financials & Analysis | aftermarkets

Sign in Register

: 287%; ₹4,768.9 cr cash on ₹1,658.9 cr profit
: ₹1,227 cr; 3.1× net profit
Debt / equity: 0.54; debt ₹3,892 cr, Sep 26
Promoter pledge: …; safety check
Default risk: …; safety check, from the Altman Z-score

Current ratio Not in our data

Needs current assets and current liabilities from the latest annual balance sheet filed with the exchange.

Operating cash as % of net profiteach fiscal year

203%—1,330%128%308%

FY22FY23FY24FY25FY26

100%: all profit arrived as cash

Operating cash vs net profit₹ cr

Year	Operating cash	Net profit	Conversion
FY22	838	413	203%
FY23	661	−65	—
FY24	971	73	1,330%
FY25	1,072	839	128%
FY26	1,227	399	308%
FY22–26	4,769	1,659	287%

Total debt₹ cr, period end

2,8303,1923,6773,6642,4372,5993,2203,892

Mar 21Mar 22Mar 23Mar 24Mar 25Sep 25Mar 26Sep 26

Debt to equitydebt ÷ (share capital + reserves), period end

0.600.600.680.670.390.390.450.54

Mar 21Mar 22Mar 23Mar 24Mar 25Sep 25Mar 26Sep 26

Every safety check Balance sheet